IP Library Granted Patent US 8,293,482
Granted Patent B2
US 8,293,482 · App. 12/704,824 · Granted Oct 23, 2012

Fibronectin type III domain based scaffold compositions, methods and uses

Assignee: Centocor Ortho Biotech Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,293,482
App. No.
12/704,824
Granted
Oct 23, 2012
Kind
B2
Abstract

A protein scaffold based on a consensus sequence of the tenth fibronectin type III (FN3) repeat from human fibronectin, including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG based on the consensus sequence have been identified as useful for diagnostic and/or therapeutic applications.

Claims (2)

1. An isolated protein scaffold based on a fibronectin type III (FN3) domain comprising the amino acid sequence of SEQ ID NO:16.

2. A library produced by providing a polypeptide having the amino acid sequence of SEQ ID NO:16; and introducing diversity into copies of the polypeptide by mutating at least one loop region of residues 22-28 and 75-81 of SEQ ID NO:16 to form the protein scaffold library.

Continuity (2)
Provisional Application 61151987 · Feb 12, 2009
Related Publication 20100255056A1 · Oct 7, 2010